Table 1.

Factors Associated with Interest in Starting Antiretroviral Therapy to Decrease HIV Transmission Risk Among 136 HIV Clinic Patients not Taking Antiretroviral Therapy

	Overall population n = 136		Interested in ART to decrease HIV transmission n = 76 (56%)		Not interested in ART to decrease HIV transmission n = 60 (44%)
Variable	N	% of total^a	N	% of each group^b	N	% of each group^b	Unadjusted relative risk (95% CI)
Survey phase
Phase 1	48	35	25	52	23	48	Reference
Phase 2	42	31	24	57	18	43	1.1 (0.8–1.7)
Phase 3	46	34	27	59	19	41	1.1 (0.8–1.7)
Gender^c
Male	101	74	56	56	45	45	Reference
Female	33	24	19	58	14	42	1.0 (0.7–1.5)
Missing	1	1	0	0	1	100
Age
< 50 years	101	74	64	63	37	37	Reference
≥ 50 years	31	23	11	35	20	65	0.6 (0.3–0.9)
Missing	4	3	1	25	3	75
Race^d
White	75	55	41	55	34	45	Reference
African American	41	30	24	59	17	41	1.1 (0.8–1.5)
Missing	5	4	2	40	3	60
Hispanic ethnicity^e	12	9	5	42	7	58	0.7 (0.4–1.4)
Education
High school or less	65	48	39	60	26	40	Reference
Beyond high school	66	49	34	52	33	48	0.9 (0.6–1.2)
Missing	5	4	3	60	2	40
Income
Less than $15,000	89	65	51	57	38	43	Reference
$15–30,000	25	18	14	56	11	44	1.0 (0.7–1.4)
More than $30,000	20	15	10	50	10	50	0.9 (0.5–1.4)
Missing	2	1	1	50	1	50
Time since diagnosis of HIV
< 1 year	15	11	11	73	4	27	Reference
1–5 years	35	26	19	54	16	46	0.7 (0.5–1.1)
5–10 years	28	21	18	64	10	36	0.9 (0.6–1.3)
>10 years	48	35	26	54	22	46	0.7 (0.5–1.1)
Missing	10	7	2	20	8	80
Sexual identity^d
Gay or bisexual man	72	53	41	57	31	43	Reference
Heterosexual man	24	18	14	58	10	42	1.0 (0.7–1.5)
Heterosexual woman	27	20	16	59	11	41	1.0 (0.7–1.5)
Missing	3	2	1	33	2	67
Number of anal or vaginal sex partners in the past year
0	43	32	24	56	19	44	Reference
1	31	23	18	58	13	42	1.0 (0.7–1.6)
2 to 5	25	18	16	64	9	36	1.1 (0.8–1.7)
6 to 10	11	8	6	55	5	45	1.0 (0.5–1.8)
> 10	16	12	7	44	9	56	0.8 (0.4–1.5)
Missing	10	7	5	50	5	50
Reported nonconcordant unprotected anal or vaginal intercourse in the past year
No	87	64	48	55	39	45	Reference
Yes	47	35	26	55	21	45	1.0 (0.7–1.4)
Missing	2	1	2	100	0	0
Nonconcordant primary partner
No	91	67	50	55	41	45	Reference
Yes	44	32	25	57	19	43	1.0 (0.8–1.4)
Missing	1	1	1	100	0	0
Always disclose HIV status to anal/vaginal sex partners
No	53	39	31	58	22	42	Reference
Yes	69	51	38	55	31	45	0.9 (0.7–1.3)
Missing	14	10	7	50	7	50
Believed that ART decreases HIV transmission^f
No/don't know	110	81	64	58	46	42	Reference
Yes	25	18	12	48	13	52	0.8 (0.5–1.3)
Missing	1	1	0	0	1	100
Believed providers should offer ART to prevent transmission
No/don't know	50	37	16	32	34	68	Reference
Yes	79	58	56	71	23	29	2.2 (1.4–3.4)
Missing	7	5	4	57	3	43
Diagnosed with gonorrhea, chlamydial infection, or syphilis in the past year^g	33	24	21	64	12	36	1.2 (0.9–1.6)
Methamphetamine use
No	70	51	42	60	28	40	Reference
Yes	34	25	18	53	16	47	0.9 (0.6–1.3)
Missing	32	24	16	50	16	50
Current or past injection drug use
No	85	63	48	56	37	43	Reference
Yes	48	35	26	54	22	46	1.0 (0.7–1.3)
Missing	3	2	2	67	1	33

^{^a}

Percentages sum to 100% across rows.

^{^b}

Percentages sum to 100% across columns (within variable groups).

^{^c}

Data from one transgendered patient were excluded from the gender analysis.

^{^d}

Data from participants of other races and sexual identities were omitted from this table due to small sample sizes.

^{^e}

Hispanic ethnicity data were missing from 8 (6%) surveys.

^{^f}

This question was asked prior to the question about interest in ART to prevent transmission.

^{^g}

We could not distinguish missing data from “no” due to the way this question was asked in the survey.

ART, antiretroviral therapy.